ATE228846T1 - Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes - Google Patents

Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes

Info

Publication number
ATE228846T1
ATE228846T1 AT95915223T AT95915223T ATE228846T1 AT E228846 T1 ATE228846 T1 AT E228846T1 AT 95915223 T AT95915223 T AT 95915223T AT 95915223 T AT95915223 T AT 95915223T AT E228846 T1 ATE228846 T1 AT E228846T1
Authority
AT
Austria
Prior art keywords
pct
digestive tract
biopolymers
sec
date
Prior art date
Application number
AT95915223T
Other languages
English (en)
Inventor
Denis Barritault
Jean-Pierre Caruelle
Anne Meddahi
Original Assignee
Valbiofrance
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valbiofrance filed Critical Valbiofrance
Application granted granted Critical
Publication of ATE228846T1 publication Critical patent/ATE228846T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95915223T 1994-03-30 1995-03-29 Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes ATE228846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403804A FR2718023B1 (fr) 1994-03-30 1994-03-30 Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
PCT/FR1995/000399 WO1995026737A1 (fr) 1994-03-30 1995-03-29 Utilisation de biopolymeres pour le traitement de lesions du tractus digestif

Publications (1)

Publication Number Publication Date
ATE228846T1 true ATE228846T1 (de) 2002-12-15

Family

ID=9461615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915223T ATE228846T1 (de) 1994-03-30 1995-03-29 Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes

Country Status (9)

Country Link
US (1) US5852004A (de)
EP (1) EP0752863B1 (de)
JP (1) JPH10506606A (de)
AT (1) ATE228846T1 (de)
CA (1) CA2186757C (de)
DE (1) DE69529063T2 (de)
ES (1) ES2188655T3 (de)
FR (1) FR2718023B1 (de)
WO (1) WO1995026737A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2268476A1 (en) * 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
FR2781374B1 (fr) * 1998-07-21 2001-06-29 Denis Barritault Composition antioxydante comprenant au moins un polymere ou biopolymere seul ou associe a la sod
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
FR2861308A1 (fr) 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
CN102885849B (zh) 2003-10-28 2017-09-22 器官组织再生修复替换公司-Otr3 使用生物相容聚合物，制备一种化合物或制造一种医用设备
EP2974718A1 (de) * 2005-04-29 2016-01-20 Cubist Pharmaceuticals, Inc. Therapeutische zusammensetzungen
DK2280720T3 (en) 2008-03-27 2019-06-11 Purdue Research Foundation COLLAGEN BINDING SYNTHETIC PEPTIDOGLYCANES, MANUFACTURING AND PROCEDURE FOR USE
HUE031596T2 (en) 2011-05-24 2017-07-28 Symic Ip Llc Synthetic peptidoglycans that bind hyaluronic acid, their production and use
BR112015022917A2 (pt) 2013-03-15 2017-07-18 Symic Biomedical Inc peptidoglicanos sintéticos componentes da matriz extracelular
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
EP3097922A1 (de) 2015-05-28 2016-11-30 Denis Barritault Zusammensetzung für die behandlung von gewebeläsionen
US10385113B2 (en) 2016-03-30 2019-08-20 The Board Of Trustees Of The University Of Arkansas Engineered FGF compositions and methods of use thereof
EP3648774A4 (de) 2017-07-07 2021-04-21 Symic IP, LLC Synthetische biokonjugate
US11267855B2 (en) 2018-03-16 2022-03-08 The Board Of Trustees Of The University Of Arkansas Engineered FGF1 and FGF2 compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461724A1 (fr) * 1979-07-20 1981-02-06 Christine Fougnot Polymeres substitues par des groupes leur conferant des proprietes anti-coagulantes et leur procede de preparation, objets constitues par et/ou comprenant lesdits polymeres et leurs procedes de fabrication, application desdits objets en chirurgie et en medecine, et compositions pharmaceutiques contenant lesdits polymeres substitues
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
FR2644066B1 (fr) * 1989-03-09 1994-05-13 Therapeutiques Substitutives Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Also Published As

Publication number Publication date
FR2718023A1 (fr) 1995-10-06
JPH10506606A (ja) 1998-06-30
CA2186757A1 (fr) 1995-10-12
US5852004A (en) 1998-12-22
EP0752863B1 (de) 2002-12-04
DE69529063T2 (de) 2003-09-11
WO1995026737A1 (fr) 1995-10-12
EP0752863A1 (de) 1997-01-15
CA2186757C (fr) 2007-10-30
ES2188655T3 (es) 2003-07-01
DE69529063D1 (de) 2003-01-16
FR2718023B1 (fr) 1996-08-14

Similar Documents

Publication Publication Date Title
ATE228846T1 (de) Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes
DE69523745D1 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
IL112111A (en) Peptides having growth hormone releasing properties and pharmaceutical compositions containing them
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE220556T1 (de) Die verwendung von lactoperoxidase, einem peroxiddonor und thiocyanat zur herstellung eines medikaments zur behandlung einer infektion mit helicobacter pylori
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
ATE367808T1 (de) N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren
ATE303817T1 (de) Verwendung von osteoprotegerin zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE69531150D1 (de) Verwendung von biopolymeren zur behandlung der muskeln
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
BR0213479A (pt) Utilização do irbesartan para a preparação de medicamentos úteis para a prevenção ou o tratamento da hipertensão pulmonar
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
FR2718025B1 (fr) Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
MY135972A (en) Egg anti-inflammatory composition and method of treating and preventing inflammation
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE69901843D1 (de) Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel
ES2188754T3 (es) Componente b como cicatrizante.
ATA57894A (de) Mittel zur behandlung von osteoporose
ATE312611T1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0752863

Country of ref document: EP

REN Ceased due to non-payment of the annual fee